製品の概要

  • 製品名Anti-SP3 antibody
    SP3 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to SP3
  • アプリケーション適用あり: IHC-P, WBmore details
  • 種交差性
    交差種: Human
    交差が予測される動物種: Mouse, Rat, Rabbit, Horse, Chicken, Guinea pig, Cow, Cat, Dog
  • 免疫原

    Synthetic peptide from within residues: AGINADGHLI NTGQAMDSSD NSERTGERVS PDINETNTDT DLFVPTSSSS, corresponding to internal sequence amino acids 288-337 of Human SP3 (NP_003102).

  • ポジティブ・コントロール
    • Human fetal muscle lysate

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab87091 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
IHC-P Use a concentration of 5 µg/ml.
WB Use a concentration of 1 µg/ml. Predicted molecular weight: 82 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.

ターゲット情報

  • 機能Transcriptional factor that can act as an activator or repressor depending on isoform and/or post-translational modifications. Binds to GT and GC boxes promoter elements. Competes with SP1 for the GC-box promoters. Weak activator of transcription but can activate a number of genes involved in different processes such as cell-cycle regulation, hormone-induction and house-keeping.
  • 組織特異性Ubiquitously expressed.
  • 配列類似性Belongs to the Sp1 C2H2-type zinc-finger protein family.
    Contains 3 C2H2-type zinc fingers.
  • 翻訳後修飾Not glycosylated.
    Acetylated by histone acetyltransferase p300, deacetylated by HDACs. Acetylation/deacetylation states regulate transcriptional activity. Acetylation appears to activate transcription. Alternate sumoylation and acetylation at Lys-551 also control transcriptional activity. Ceramides can also regulate acetylation/deacetylation events through altering the interaction of HDAC with SP3. In vitro, C(18)-ceramides, but not C(16)-ceramides, increase the interaction of HDAC1 with SP3 and enhance the deacetylation of SP3 and the subsequent repression of the TERT promoter.
    Sumoylated on all isoforms. Sumoylated on 2 sites in longer isoforms with Lys-551 being the major site. Sumoylation at this site promotes nuclear localization to the nuclear periphery, nuclear dots and PML nuclear bodies. Sumoylation on Lys-551 represses the transactivation activity, except for the largest isoform, L-Sp3, which has little effect on transactivation. Alternate sumoylation and acetylation at Lys-551 also control transcriptional activity.
  • 細胞内局在Nucleus. Nucleus > PML body. Localizes to the nuclear periphery and in nuclear dots when sumoylated. Some localization in PML nuclear bodies.
  • Information by UniProt
  • 参照データベース
  • 別名
    • D130027J01Rik antibody
    • DKFZp686O1631 antibody
    • GC binding transcription factor Sp 3 antibody
    • GC binding transcription factor Sp3 antibody
    • MGC105187 antibody
    • OTTMUSP00000014207 antibody
    • SP 3 antibody
    • Sp 3 transcription factor antibody
    • SP3 antibody
    • Sp3 transcription factor antibody
    • SP3_HUMAN antibody
    • Specificity protein 3 antibody
    • SPR 2 antibody
    • SPR-2 antibody
    • SPR2 antibody
    • Transcription factor SP 3 antibody
    • Transcription factor Sp3 antibody
    see all

Anti-SP3 antibody 画像

  • Anti-SP3 antibody (ab87091) at 1 µg/ml + Fetal muscle lysate at 10 µg

    Secondary
    HRP conjugated anti-Rabbit IgG at 1/50000 dilution

    Predicted band size : 82 kDa
    Observed band size : >90 kDa (why is the actual band size different from the predicted?)
    Gel concentration: 12%
  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human prostate tissue labelling SP3 with ab87091 at 5.0µg/ml.

Anti-SP3 antibody (ab87091) 使用論文

ab87091 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab87091.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"